Literature DB >> 21527525

Activation of factor XI by products of prothrombin activation.

Anton Matafonov1, Suryakala Sarilla, Mao-fu Sun, John P Sheehan, Vladimir Serebrov, Ingrid M Verhamme, David Gailani.   

Abstract

The prothrombinase complex converts prothrombin to α-thrombin through the intermediate meizothrombin (Mz-IIa). Both α-thrombin and Mz-IIa catalyze factor (F) XI activation to FXIa, which sustains α-thrombin production through activation of FIX. The interaction with FXI is thought to involve thrombin anion binding exosite (ABE) I. α-Thrombin can undergo additional proteolysis to β-thrombin and γ-thrombin, neither of which have an intact ABE I. In a purified protein system, FXI is activated by β-thrombin or γ-thrombin, and by α-thrombin in the presence of the ABE I-blocking peptide hirugen, indicating that a fully formed ABE I is not absolutely required for FXI activation. In a FXI-dependent plasma thrombin generation assay, β-thrombin, γ-thrombin, and α-thrombins with mutations in ABE I are approximately 2-fold more potent initiators of thrombin generation than α-thrombin or Mz-IIa, possibly because fibrinogen, which binds to ABE I, competes poorly with FXI for forms of thrombin lacking ABE I. In addition, FXIa can activate factor FXII, which could contribute to thrombin generation through FXIIa-mediated FXI activation. The data indicate that forms of thrombin other than α-thrombin contribute directly to feedback activation of FXI in plasma and suggest that FXIa may provide a link between tissue factor-initiated coagulation and the proteases of the contact system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527525      PMCID: PMC3138693          DOI: 10.1182/blood-2010-10-312983

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Differential activation and inhibition of human platelet thrombin receptors by structurally distinct alpha-, beta- and gamma-thrombin.

Authors:  Gerald Soslau; Seth J Goldenberg; Reiner Class; Bradford Jameson
Journal:  Platelets       Date:  2004-05       Impact factor: 3.862

2.  Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin.

Authors:  A Bezeaud; M H Denninger; M C Guillin
Journal:  Eur J Biochem       Date:  1985-12-16

3.  Phosphatidylethanolamine participates in the stimulation of the contact system of coagulation by very-low-density lipoproteins.

Authors:  S Klein; M Spannagl; B Engelmann
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-10       Impact factor: 8.311

4.  Covalent structures of beta and gamma autolytic derivatives of human alpha-thrombin.

Authors:  J P Boissel; B Le Bonniec; M J Rabiet; D Labie; J Elion
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

5.  [Procoagulant properties of beta/gamma-thrombin].

Authors:  O A Semenova; S M Strukova
Journal:  Vopr Med Khim       Date:  1982 Jul-Aug

6.  Role of prothrombin fragment 1 in the pathway of regulatory exosite I formation during conversion of human prothrombin to thrombin.

Authors:  Patricia J Anderson; Paul E Bock
Journal:  J Biol Chem       Date:  2003-08-25       Impact factor: 5.157

7.  Prothrombotic markers in familial combined hyperlipidemia: evidence of endothelial cell activation and relation to metabolic syndrome.

Authors:  Anna M Georgieva; Hugo Ten Cate; Eric T P Keulen; René van Oerle; José W P Govers-Riemslag; Karly Hamulyák; Carla J H van der Kallen; Marleen M J Van Greevenbroek; Tjerk W A De Bruin
Journal:  Atherosclerosis       Date:  2004-08       Impact factor: 5.162

8.  Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet glycoprotein Ib alpha with thrombin anion-binding exosites I and II, respectively.

Authors:  Thomas H Yun; Frank A Baglia; Timothy Myles; Duraiswamy Navaneetham; José A López; Peter N Walsh; Lawrence L K Leung
Journal:  J Biol Chem       Date:  2003-09-10       Impact factor: 5.157

9.  Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).

Authors:  J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

Review 10.  Molecular recognition mechanisms of thrombin.

Authors:  J A Huntington
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

View more
  35 in total

Review 1.  The Intrinsic Pathway of Coagulation as a Target for Antithrombotic Therapy.

Authors:  Allison P Wheeler; David Gailani
Journal:  Hematol Oncol Clin North Am       Date:  2016-10       Impact factor: 3.722

2.  Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates.

Authors:  C Puy; E I Tucker; Z C Wong; D Gailani; S A Smith; S H Choi; J H Morrissey; A Gruber; O J T McCarty
Journal:  J Thromb Haemost       Date:  2013-07       Impact factor: 5.824

Review 3.  Factor XI and contact activation as targets for antithrombotic therapy.

Authors:  D Gailani; C E Bane; A Gruber
Journal:  J Thromb Haemost       Date:  2015-06-16       Impact factor: 5.824

4.  The evolution of factor XI and the kallikrein-kinin system.

Authors:  Michał B Ponczek; Aleksandr Shamanaev; Alec LaPlace; S Kent Dickeson; Priyanka Srivastava; Mao-Fu Sun; Andras Gruber; Christian Kastrup; Jonas Emsley; David Gailani
Journal:  Blood Adv       Date:  2020-12-22

5.  Factor XI anion-binding sites are required for productive interactions with polyphosphate.

Authors:  Y Geng; I M Verhamme; S A Smith; Q Cheng; M Sun; J P Sheehan; J H Morrissey; D Gailani
Journal:  J Thromb Haemost       Date:  2013-11       Impact factor: 5.824

6.  The Fragment 1 Region of Prothrombin Facilitates the Favored Binding of Fragment 12 to Zymogen and Enforces Zymogen-like Character in the Proteinase.

Authors:  Harlan N Bradford; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2016-03-24       Impact factor: 5.157

7.  Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.

Authors:  Yuichi Kamikubo; G Loredana Mendolicchio; Antonella Zampolli; Patrizia Marchese; Andrea S Rothmeier; Jennifer Nagrampa Orje; Andrew J Gale; Sriram Krishnaswamy; András Gruber; Henrik Østergaard; Lars C Petersen; Wolfram Ruf; Zaverio M Ruggeri
Journal:  Blood       Date:  2017-07-20       Impact factor: 22.113

Review 8.  Plasma contact factors as therapeutic targets.

Authors:  Benjamin F Tillman; Andras Gruber; Owen J T McCarty; David Gailani
Journal:  Blood Rev       Date:  2018-04-12       Impact factor: 8.250

9.  A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.

Authors:  Yasin Kokoye; Ivan Ivanov; Qiufang Cheng; Anton Matafonov; S Kent Dickeson; Shauna Mason; Daniel J Sexton; Thomas Renné; Keith McCrae; Edward P Feener; David Gailani
Journal:  Thromb Res       Date:  2016-02-18       Impact factor: 3.944

Review 10.  Inhibition of Factors XI and XII for Prevention of Thrombosis Induced by Artificial Surfaces.

Authors:  Benjamin Tillman; David Gailani
Journal:  Semin Thromb Hemost       Date:  2017-09-12       Impact factor: 4.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.